This is a demo store. No orders will be fulfilled.

Lorbriqua

Lorbriqua (Lorlatinib) is a targeted therapy designed for the treatment of advanced non-small cell lung cancer (NSCLC) with specific genetic mutations.

In stock

SKU
Lorbriqua
Strength:
As low as: USD $2,382.00
Write Your Own Review
You're reviewing: Lorbriqua
Your Rating:
Quality
Value
Price
loader
Loading...

You submitted your review for moderation.